Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Outline of Final Research Achievements |
We have focused on epithelial-mesenchymal transition (EMT) as a mechanism of cancer progression and reported that polycomb repressive complex 2 (PRC2), which is one of epigenetic regulators, induces EMT by repressing the expression of epithelial genes. In this study, we proposed that MEG3 long noncoding RNA guides PRC2 to its target gene loci. These results contribute to understanding of long noncoding RNA involved in cancer progression.
|